Company Profile For Phase Forward Incorporated

Phase Forward Incorporated (PFWD.O) (Nasdaq)
sector: Industrials · industry: Commercial Services & Supplies ·
As of  27 Nov 2009
15.48USD
Price Change
-0.43
Percent Change
-2.70%
 
 
Research a stock:   symbol lookup

Overview

Phase Forward Incorporated is a provider of integrated enterprise-level software products, services and hosted solutions for use in the global clinical trial and drug safety monitoring activities. The Company customers include pharmaceutical, biotechnology and medical device companies, as well as academic institutions, governmental regulatory agencies, contract research organizations (CROs), and other entities engaged in clinical trial and drug safety monitoring activities. Its electronic data capture (EDC) and clinical data management products are designed to provide clients with enterprise-level automation of paper-based clinical trial processes and to scale clinical trials involving clinical sites and patients worldwide. The Company refers to this unified interactive system as its interactive response technology (IRT). In September 2008, the Company acquired Clarix LLC. In April 2009, the Company acquired Waban Software. In July 2009, the Company acquired Maaguzi LLC.

Quick Financial Synopsis

BRIEF: For the six months ended 30 June 2009, Phase Forward Incorporated revenues increased 28% to $101.3M. Net income decreased 18% to $6.3M. Revenues reflect an increase in income from Licenses and higher income from Services. Net income was offset by an increase in sales & marketing expenses, higher research & development expenses, an increase in general & administration expenses and lower interest income.

Company Address

Phase Forward Incorporated
880 Winter Street
Waltham   MA   02451
P: +1888.7031122
F: +1781.8904848

Total Employees

718

Find Out More About PFWD.O

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement